FR2952059B1 - Anticorps chimerique anti ricine - Google Patents

Anticorps chimerique anti ricine

Info

Publication number
FR2952059B1
FR2952059B1 FR0957786A FR0957786A FR2952059B1 FR 2952059 B1 FR2952059 B1 FR 2952059B1 FR 0957786 A FR0957786 A FR 0957786A FR 0957786 A FR0957786 A FR 0957786A FR 2952059 B1 FR2952059 B1 FR 2952059B1
Authority
FR
France
Prior art keywords
ricin
chimeric antibody
chimeric
antibody
ricin chimeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0957786A
Other languages
English (en)
Other versions
FR2952059A1 (fr
Inventor
Philippe Thullier
Alexandre Fontayne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Etat Francais Represente Par Le Delegue Genera Fr
LFB SA
Original Assignee
Direction General pour lArmement DGA
LFB Biotechnologies SAS
Etat Francais
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Direction General pour lArmement DGA, LFB Biotechnologies SAS, Etat Francais filed Critical Direction General pour lArmement DGA
Priority to FR0957786A priority Critical patent/FR2952059B1/fr
Priority to ARP100104096A priority patent/AR078914A1/es
Priority to PCT/FR2010/052375 priority patent/WO2011055088A1/fr
Priority to US13/508,108 priority patent/US8535668B2/en
Priority to EP10792969A priority patent/EP2496602A1/fr
Publication of FR2952059A1 publication Critical patent/FR2952059A1/fr
Application granted granted Critical
Publication of FR2952059B1 publication Critical patent/FR2952059B1/fr
Priority to US13/967,977 priority patent/US20140050722A1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR0957786A 2009-11-04 2009-11-04 Anticorps chimerique anti ricine Expired - Fee Related FR2952059B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0957786A FR2952059B1 (fr) 2009-11-04 2009-11-04 Anticorps chimerique anti ricine
ARP100104096A AR078914A1 (es) 2009-11-04 2010-11-04 Anticuerpo quimerico anti ricina
PCT/FR2010/052375 WO2011055088A1 (fr) 2009-11-04 2010-11-04 Anticorps chimerique anti ricine
US13/508,108 US8535668B2 (en) 2009-11-04 2010-11-04 Chimeric anti-ricin antibody
EP10792969A EP2496602A1 (fr) 2009-11-04 2010-11-04 Anticorps chimerique anti ricine
US13/967,977 US20140050722A1 (en) 2009-11-04 2013-08-15 Chimeric anti-ricin antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0957786A FR2952059B1 (fr) 2009-11-04 2009-11-04 Anticorps chimerique anti ricine

Publications (2)

Publication Number Publication Date
FR2952059A1 FR2952059A1 (fr) 2011-05-06
FR2952059B1 true FR2952059B1 (fr) 2011-12-16

Family

ID=42227649

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0957786A Expired - Fee Related FR2952059B1 (fr) 2009-11-04 2009-11-04 Anticorps chimerique anti ricine

Country Status (5)

Country Link
US (2) US8535668B2 (fr)
EP (1) EP2496602A1 (fr)
AR (1) AR078914A1 (fr)
FR (1) FR2952059B1 (fr)
WO (1) WO2011055088A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10208108B2 (en) * 2014-11-28 2019-02-19 The Israel Institute of Biological Research (IIBR) Antibodies directed to ricin toxin
US10233256B2 (en) * 2014-11-28 2019-03-19 The Israel Institute of Biological Research (IIBR) Antibodies directed to ricin toxin
US11440951B2 (en) 2017-03-13 2022-09-13 The Government Of The United States, As Represented By The Secretary Of The Army Therapeutic antibodies to Marburg virus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756096A (en) * 1991-07-25 1998-05-26 Idec Pharmaceuticals Corporation Recombinant antibodies for human therapy
US5626844A (en) * 1991-11-04 1997-05-06 The United States Of America As Represented By The Secretary Of The Army Monoclonal antibody against ricin A chain
FR2922212B1 (fr) 2007-10-11 2011-11-11 France Etat Anticorps anti ricine

Also Published As

Publication number Publication date
US20120258100A1 (en) 2012-10-11
US20140050722A1 (en) 2014-02-20
US8535668B2 (en) 2013-09-17
FR2952059A1 (fr) 2011-05-06
EP2496602A1 (fr) 2012-09-12
AR078914A1 (es) 2011-12-14
WO2011055088A1 (fr) 2011-05-12

Similar Documents

Publication Publication Date Title
LTPA2019011I1 (lt) CGRP antikūnai
SMT201700083B (it) Anticorpi monoclonali
BRPI1006519A2 (pt) formulação de anticorpos
BR112012030311A2 (pt) anticorpo
BRPI1011005A2 (pt) anticorpos anti-epcam
BRPI0907237A2 (pt) Anticorpo anti-cldn6
DK2521736T3 (da) Humaniserede antistoffer
ES2897500T8 (es) Formulaciones de anticuerpos T1h
DK2459167T3 (da) SUBKUTAN ANTI-HER2-antistofformulering
BRPI0906877A2 (pt) Anticorpos anti-trkb aperfeiçoados
DK2274012T3 (da) Cytotoksisk immunoglobulin
BRPI1011145A2 (pt) anticorpo anti-axl
BRPI0907532A2 (pt) Anticorpos anti-c5ar humanizados
BR112013010688A2 (pt) anticorpos anti c-met
DK3323830T3 (da) Anti-gd2 antibodies
BR112012024025A2 (pt) conjunto de sensor
CR20130228A (es) Anticuerpos neutralizadores anti-ccl20
BRPI1008782A2 (pt) primidinas fundidas
DK3351255T3 (da) Modificerede anti-cd4-antistoffer
CO6791565A2 (es) Anticuerpos anti-notch1
BR112012000281A2 (pt) proteína quimérica.
BR112012005960A2 (pt) n-fenil-1-(4-piridinil)-1h-pirazol-3-aminas substituídas
BRPI0909633A2 (pt) anticorpos anti-tyrp1
DE112010000691A5 (de) Chromatographievorrichtung
BRPI1010706A2 (pt) veículo

Legal Events

Date Code Title Description
TQ Partial transmission of property

Owner name: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES , FR

Effective date: 20131219

Owner name: ETAT FRANCAIS REPRESENTE PAR LE DELEGUE GENERA, FR

Effective date: 20131219

ST Notification of lapse

Effective date: 20160729